Inhibition of EZH2 by GSK-126, a pharmacological analogy to Weaver syndrome, stimulates osteoblast differentiation in mice (66), while GSK-J4 reduced osteogenesis in a mouse model of Saethre-Chotzen craniosynostosis (MIM 101400) (67). The gene discussed is EZH2; the disease is Weaver syndrome.